JXPCB(SH:688655)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥106,514,751.33, representing a year-on-year increase of 3.56%[4] - Net profit attributable to shareholders was ¥6,249,335.84, a significant increase of 101.45% compared to the same period last year[4] - The net cash flow from operating activities reached ¥17,204,829.16, up by 116.37% year-on-year[4] - Basic earnings per share were ¥0.05, reflecting a 150.00% increase from the previous year[4] - The company reported a total comprehensive income of CNY 6,248,623.90 for Q1 2023, compared to CNY 3,102,330.27 in Q1 2022, reflecting a 101.5% increase[19] - The net profit for Q1 2023 was CNY 6,249,335.84, representing a 101.5% increase compared to CNY 3,102,208.33 in Q1 2022[18] - Operating profit for Q1 2023 reached CNY 6,672,100.29, up 96.7% from CNY 3,395,637.45 in the same period last year[18] - The company's total revenue for Q1 2023 was CNY 100,622,315.34, representing an increase of 1.69% compared to CNY 98,953,867.24 in Q1 2022[29] - The net profit for Q1 2023 was CNY 5,577,433.90, up 19.7% from CNY 4,657,202.86 in Q1 2022[29] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥1,026,386,956.12, a decrease of 1.88% from the end of the previous year[5] - Total assets decreased to RMB 1,026,386,956.12 as of March 31, 2023, from RMB 1,046,092,024.66 at the end of 2022, a decline of 1.9%[14] - Total liabilities decreased to RMB 335,600,793.11 from RMB 361,555,367.79, representing a reduction of 7.2%[15] - The company's equity attributable to shareholders increased to RMB 690,786,163.01 from RMB 684,536,656.87, showing a slight increase of 0.4%[15] - The company's total assets as of March 31, 2023, were CNY 704,852,993.27, compared to CNY 709,834,609.27 at the end of 2022[25] - The total assets decreased slightly to CNY 704,852,993.27 from CNY 709,834,609.27 in the previous quarter[26] - Total liabilities decreased to CNY 109,055,271.87 from CNY 119,614,321.77 in the previous quarter[26] Cash and Cash Equivalents - Cash and cash equivalents as of March 31, 2023, amounted to RMB 240,899,358.74, compared to RMB 219,433,885.66 at the end of 2022, indicating a growth of 9.3%[13] - The cash and cash equivalents at the end of Q1 2023 amounted to CNY 233,408,912.02, an increase from CNY 123,694,967.15 at the end of Q1 2022[22] - The company's cash and cash equivalents at the end of Q1 2023 were CNY 202,630,799.04, an increase from CNY 103,336,145.73 at the end of Q1 2022[34] Research and Development - R&D investment totaled ¥7,256,997.79, which is a decrease of 3.88% year-on-year, accounting for 6.81% of operating revenue[4] - Research and development expenses for Q1 2023 were CNY 7,256,997.79, slightly down from CNY 7,549,596.74 in Q1 2022[18] - Research and development expenses for Q1 2023 were CNY 3,469,218.30, down from CNY 4,036,187.10 in Q1 2022[29] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,233[9] - The top shareholder, Ma Zhuo, holds 38.66% of the shares, totaling 51,573,100 shares[9] Future Outlook - Future outlook includes potential market expansion and new product development strategies, although specific details were not disclosed in the current report[17] - The company plans to continue expanding its market presence and investing in new technologies[29]